Cargando…
MSC-Exosomes Carrying miRNA – Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19?
[Image: see text]
Autores principales: | Schultz, Iago C., Bertoni, Ana Paula S., Wink, Márcia Rosângela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261118/ https://www.ncbi.nlm.nih.gov/pubmed/35794511 http://dx.doi.org/10.1007/s12015-022-10409-w |
Ejemplares similares
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
por: Schultz, Iago Carvalho, et al.
Publicado: (2021) -
Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients
por: Schultz, Iago C., et al.
Publicado: (2022) -
HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice
por: Wang, Gaoying, et al.
Publicado: (2020) -
NTPDase5/PCPH as a New Target in Highly Aggressive Tumors: A Systematic Review
por: Bracco, Paula Andreghetto, et al.
Publicado: (2014) -
MBRS-27. EXOSOMES CARRY DISTINCT miRNAs THAT DRIVE MEDULLOBLASTOMA PROGRESSION
por: Jackson, Hannah K, et al.
Publicado: (2020)